NeuroPace, Inc.
NPCE
Rank in Stocks
#12659
NeuroPace, Inc. operates as a medical device company in the United States. The... NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet which is used for prescribing and managing clinicians for programming implanted devices and managing patient care; and patient data management system, a secure online database that collects data that have been recorded by the RNS System; and nSight Platform, which provide clinicians with personalized patient reports, as well as programming suggestions. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
Share Price
$13.12
Last synced: 2026-11-09
Market Cap
$450.33M
Change (1 day)
4.96%
Change (1 year)
-2.74%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade NeuroPace, Inc. (NPCE)
Category
Healthcare
EPS for NeuroPace, Inc. (NPCE)
EPS as of June 2026 TTM: $-0.57
According to NeuroPace, Inc.'s latest financial reports, its current EPS (TTM) is $-0.57. At the end of 2025 the company had an EPS of $-0.66, an increase over its 2024 EPS of $-0.93.
EPS history for NeuroPace, Inc. from 2019 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.57 | -13.64% |
| 2025 | $-0.66 | -29.03% |
| 2024 | $-0.93 | -26.77% |
| 2023 | $-1.27 | -33.51% |
| 2022 | $-1.91 | -11.98% |
| 2021 | $-2.17 | 0.00% |
| 2020 | $-2.17 | -19.63% |
| 2019 | $-2.70 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $2.70 | -573.68% |
US
|
|
| $4.09 | -817.54% |
IE
|
|
| $9.45 | -1,757.89% |
US
|
|
| $2.37 | -515.79% |
US
|
|
| $1.77 | -410.53% |
US
|
Questions about NeuroPace, Inc.'s earnings per share (EPS)
What is NeuroPace, Inc.'s earnings per share (EPS)?
NeuroPace, Inc.'s earnings per share (EPS) over the last twelve months is $-0.57, as of Jun 2026.
What was NeuroPace, Inc.'s earnings per share (EPS) in 2025?
In 2025, NeuroPace, Inc.'s earnings per share (EPS) was $-0.66, compared with $-0.93 in 2024.
How has NeuroPace, Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, NeuroPace, Inc.'s earnings per share (EPS) was highest in 2025 ($-0.66) and lowest in 2021 ($-2.17).
How does NeuroPace, Inc.'s earnings per share (EPS) compare with similar companies?
NeuroPace, Inc.'s earnings per share (EPS) ($-0.57) is lower than that of all 5 similar companies listed above. The highest among them is Stryker Corporation, with $9.45.